The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Tandem Diabetes Care (Nasdaq:TNDM) shares took a bit hit after hours on second-quarter results that missed the consensus forecast.

Shares of TNDM were down 7.2% at $64 per share after the market closed, which was when it released its quarterly results.

The San Diego-based automated insulin delivery technology developer posted losses of $15.1 million, or 24¢ per share, on sales of $200.3 million for the three months ended June 30, 2022, for a roughly $20 million bottom-line slide into the red on sales growth of 16.3%.

On Wall Street, analysts had been looking for sales of $205.3 million and adjusted earnings per share of 2¢.

Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Business/Financial News, Diabetes, Drug Pumps, Drug-Device Combinations, MassDevice Earnings Roundup, News Well, Patient Monitoring, Wall Street Beat Tagged With: Tandem Diabetes Care

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.